HIV, Trump and Africa

South African scientists were testing a promising HIV vaccine. Then came Trump’s aid cuts
South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded scientists for decades, when the order came from USAID to stop work.
HIV Vaccine Trials Halted Due to Trump Administration Cuts
Scientists believe they are on the cusp of a vaccine for HIV. Two promising vaccines were set to go to additional trials. But the vials of vaccines are in the freezer due to financial cuts by the Trump administration.
US aid freeze could set back Africa’s fight against HIV by years, researchers warn
Trump’s pause in USAID spending has put major African HIV vaccine and prevention trials on hold, leaving the research world in shock
Trump's aid cuts stop South African HIV vaccine trials in their tracks
South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded scientists for decades, when the order came from USAID to stop work. The first round of vaccines she and her colleagues made in Johannesburg had produced an immune response in rabbits,
USAID Funding Freeze Puts Promising South African HIV Vaccine Trials on Hold
The development of a promising HIV vaccine led by South African researchers has been halted due to funding cuts from USAID, following U.S. President Donald Trump's policy changes. The vaccine program,
Trump's foreign aid freeze halted a crucial program fighting HIV in Africa. Here's what's at stake
The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world’s most successful responses to a disease
Trump's aid freeze sends shock waves through Africa's HIV programs
The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful responses to a disease. For two decades, the American people have paid for the President's Emergency Plan for AIDS Relief,
Healio3d
FDA sets date for decision on twice-yearly shots to prevent HIV
The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...
devdiscourse2d
Global Health Concerns: Bird Flu, HIV Trials, and Pharma Controversies
A summary of current health news highlights a bird flu outbreak in Canada, halted HIV vaccine trials in South Africa, a legal ...
HUB4h
The basics of vaccines and vaccination
Veteran vaccine researcher Arturo Casadevall gives a podcast primer on vaccinations, from how they work on a molecular level to common misconceptions ...
Science Daily2d
HIV and AIDS News
Updated Hep B Vaccine More Effective for People With HIV Dec. 10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective ...
HIV protein switch may help virus squeeze into host cell nucleus
Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...
Rolling Out10d
How new strategies are changing the fight against HIV
Efforts to create an effective HIV vaccine are ongoing, with researchers optimistic about future breakthroughs. Digital health tools, including telemedicine and mobile apps, are also improving ...
US aid freeze sows disruption in HIV, malaria product supply chains
The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases ...
Mail & Guardian6d
Trump’s funding cuts hit HIV, GBV services hard
Trump’s aid cut has also hit clinical trials. The South African Medical Research Council, which was awarded $45 million to ...